135 Duryea Rd
Melville, New York 11747-3834
Phone: 16318435500
www.henryschein.com
Henry Schein, Inc. (Nasdaq: HSIC) today announced the annual launch of its Practice Pink program, an initiative that has raised more than $1.9 million in the past 17 years to support nonprofit organizations dedicated to cancer research and prevention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231003522488/en/ (Graphic:
Unveiling Henry Schein (HSIC)''s Value: Is It Really Priced Right? A Comprehensive Guide
Henry Schein, Inc. reminds its customers in Florida and all areas in the projected path of Hurricane Idalia that the Henry
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Florida and all areas in the projected path of Hurricane Idalia that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the hurricane. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline
GUELPH, ON / ACCESSWIRE / August 24, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company has signed a Distributi…
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Hawaii that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the recent wildfires. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available
https://www.investing.com/news/pro/henry-schein-receives-investment-bank-analyst-rating-update-3147852
The S&P 500 settled higher on Monday, snapping a four-session losing streak. U.S. stocks have notched sharp gains this year, with the benchmark S&P 500 adding around 17.7% in 2023. As far as the earnings season is concerned, 422 S&P 500 companies have released quarterly results as of Friday, with around 79.1% of those exceeding market estimates. Henry Schein Inc (NASDAQ: HSIC ) reported better-than-expected second-quarter earnings. Sage Therapeutics Inc (NASDAQ: SAGE ) shares dipped around … Full story available on Benzinga.com
Henry Schein, Inc. (NASDAQ:NASDAQ:HSIC) Q2 2023 Earnings Conference Call August 7, 2023 10:00 PM ETCompany ParticipantsGraham Stanley - Vice President, Investor Relations and Strategic…
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 350 points on Monday. The Dow traded up 1.02% to 35,423.19 while the NASDAQ rose 0.24% to 13,942.57. The S&P 500, also rose, gaining, 0.65% to 4,507.13. Check This Out: Merck, Delta Air Lines And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Financials shares jumped by 1.4% on Monday. In trading on Monday, information technology shares fell 0.1%. Top Headline Henry Schein Inc (NASDAQ: HSIC ) reported better-than-expected second-quarter earnings. Henry Schein posted quarterly sales of $3.10 billion, slightly missing the consensus of $3.11 billion, up 2.3% Y/Y, including 0.2% decrease in local currencies excluding acquisitions, 2.9% growth from acquisitions, and a 0.4% decrease related to foreign currency exchange. Adjusted EPS of $1.31, up 0.8%, beat the estimate of $1.25. Equities Trading UP Vistagen Therapeutics, Inc. (NASDAQ: VTGN ) shares shot up 1,026% to $18.91 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints.